Novabiotics - a leading clinical-stage biotechnology company
Novabiotics about us Novabiotics clinical studies Novabiotics pipeline Novabiotics our news Novabiotics contact

Investors

NovaBiotics is a privately held, capital efficient business having delivered success on circa $40 million in funding raised to date.

NovaBiotics’ experienced board and management team remain focused on high-value opportunities and the delivery of commercial success from the Company’s consumer and pharmaceutical products.

To find out more about investment opportunities, contact us.